Peer-reviewed veterinary case report
Long-term control of pancreatic cancer in a cat with toceranib
By Dedeaux, Andrea M et al.·Published in The Canadian veterinary journal = La revue veterinaire canadienne·2018·Department of Veterinary Clinical Sciences (Dedeaux, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Long-term clinical control of feline pancreatic carcinoma with toceranib phosphate.
- Species:
- cat
Plain-English summary
An 11-year-old spayed female domestic shorthair cat was brought in with an abdominal mass that was found to be pancreatic cancer. The veterinarian started treatment with a medication called toceranib phosphate, but after about a year, an ultrasound showed that the cancer was getting worse. Sadly, the cat continued to show signs of illness and was humanely euthanized nearly 800 days after her initial visit.
People also search for: cat pancreatic cancer treatment · feline abdominal mass · toceranib phosphate for cats
Abstract
An 11-year-old, spayed female, domestic shorthair cat was presented with a non-resectable abdominal mass diagnosed as carcinomatosis of pancreatic origin. Treatment with toceranib phosphate was started. Abdominal ultrasound approximately 1 year after diagnosis revealed progressive disease. The cat was humanely euthanized approximately 792 days after initial presentation due to progressive clinical signs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/30026621/